Related Experiment Video
Updated: Feb 5, 2026

05:07
Characterizing Extracellular Vesicles from Biological Fluids
Published on: February 28, 2025
880
Extracellular vesicles: translational challenges and opportunities.
Hannah Clemmens1, Daniel W Lambert2,3
1Academic Unit of Oral and Maxillofacial Pathology, School of Clinical Dentistry, University of Sheffield, S10 2TA Sheffield, U.K. hsclemmens1@sheffield.ac.uk.
Biochemical Society Transactions
|September 23, 2018
Summary
Extracellular vesicles (EVs) are key to cell communication in health and disease. This review explores their diagnostic and therapeutic potential, alongside current isolation and analysis technologies for clinical use.
Area of Science:
- Biochemistry
- Cell Biology
- Nanotechnology
Background:
- Extracellular vesicles (EVs) are lipid-enclosed structures involved in intercellular communication.
- EVs play significant roles in both physiological processes and disease pathogenesis.
- Recent research highlights the potential of EVs as diagnostic and therapeutic agents.
Purpose of the Study:
- To review the translational potential of extracellular vesicles (EVs).
- To discuss current technologies for isolating, purifying, and analyzing EVs and their contents.
- To address challenges hindering the routine clinical application of EVs.
Main Methods:
- Literature review of current research on extracellular vesicles (EVs).
- Analysis of existing technologies for EV isolation, purification, and characterization.
- Discussion of the clinical applications and challenges of EV-based therapies and diagnostics.
Main Results:
- EVs show promise as biomarkers and drug delivery vehicles.
- Various methods exist for EV isolation and analysis, each with limitations.
- Significant hurdles remain in standardizing EV production and application for clinical settings.
Conclusions:
- EVs hold considerable translational potential in medicine.
- Further technological advancements and standardization are crucial for clinical implementation.
- Overcoming current challenges will enable routine use of EVs in diagnostics and therapeutics.
Related Concept Videos
Translation
156.6K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
156.6K
Translation
17.8K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.8K
Initiation of Translation
39.0K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.0K
Termination of Translation
27.7K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.7K
Termination of Translation
6.8K
6.8K
Improving Translational Accuracy
14.9K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.9K

